1. Home
  2. RPRX
  3. RPRX News

Latest Royalty Pharma plc (RPRX) News on May 28, 2024

Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline

GlobeNewswire

6 days ago

Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline

Morningstar Research

19 days ago

Analyst Report: Royalty Pharma plc

Morningstar Research

3 months ago

Analyst Report: Royalty Pharma plc

Auto & Transport Roundup: Market Talk

The Wall Street Journal

4 months ago

Auto & Transport Roundup: Market Talk

Morningstar Research

4 months ago

Analyst Report: Coinbase Global, Inc.

Share on Social Networks: